Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional, Multicenter, Multiple Cohort Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

NCT03782207 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT03782207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03782207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional, Multicenter, Multiple Cohort Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
February 7, 2019
Completion date
July 31, 2026
Enrollment
2,756 (actual)
Sites
257

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, non-small cell lung cancer, small cell lung cancer, urothelial carcinoma